| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ligand Pharmaceuticals Inc (LGND) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. LGND is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 161.3K | $35.72M | - | |
| Dir | 44.0K | $9.74M | - | |
| Dir | 33.8K | $7.48M | - | |
| Dir | 32.8K | $7.25M | - | |
| Other | 30.8K | $6.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2022 | Higgins John L66 | Chief Executive Officer | Sell | 5,000 | $89.61 | $448,050.00 | -0.7% | -29.3% | -29.4% | |
| May 13, 2022 | Foehr Matthew W72 | President And COO | Buy | 2,500 | $82.76 | $206,909.50 | +1.5% | +18.6% | -12.0% | |
| Feb 28, 2022 | Kozarich John W61 | Director | Sale+OE | 908 | $102.62 | $93,178.96 | -2.2% | -12.2% | -28.7% | |
| Nov 16, 2021 | Lamattina John L | Director | Sale+OE | 4,835 | $161.86 | $782,579.08 | -16.0% | -25.6% | -50.7% | |
| Nov 12, 2021 | Higgins John L66 | Chief Executive Officer | Sell | 3,000 | $160.50 | $481,500.00 | -0.9% | -26.0% | -49.6% | |
| Nov 11, 2021 | Foehr Matthew W72 | President And COO | Sale+OE | 11,160 | $163.02 | $1,819,255.21 | -6.3% | -22.8% | -49.8% | |
| Aug 4, 2021 | Foehr Matthew W72 | President And COO | Sale+OE | 8,840 | $109.67 | $969,506.67 | -5.1% | +44.8% | -10.6% | |
| Feb 10, 2021 | Davis Todd C77 | Director | Sale+OE | 5,083 | $213.14 | $1,083,409.94 | -9.6% | - | - | |
| Feb 9, 2021 | Sabba Stephen L | Director | Sale+OE | 14,670 | $208.53 | $3,059,122.70 | -18.9% | - | - | |
| Feb 5, 2021 | Higgins John L66 | Chief Executive Officer | Sale+OE | 54,666 | $203.40 | $11,119,239.33 | -16.0% | - | - |